The ROE (Return on Equity) of Replicel Life Sciences Inc (RP.V) is -13.33%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-03-31 | -13.33% |
| 2023-03-31 | -12.71% |
| 2022-12-31 | 12.56% |
| 2022-03-31 | -35.01% |
| 2021-12-31 | 59.53% |
| 2020-12-31 | 31.22% |
| 2019-12-31 | 67.88% |
| 2018-12-31 | 608.35% |
| 2017-12-31 | 1879.48% |
| 2016-12-31 | -354.04% |